Recent Advances in Inflammation & Allergy Drug Discovery

Formerly Recent Patents on Inflammation & Allergy Drug Discovery

Editor-in-Chief

Stefano Fiorucci
Department Of Medicine And Surgery
University of Perugia
Perugia
(Italy)

Personal Subscription
Become EABM
Become Reviewer
Call for Editor

Aims & Scope

Recent Advances in Inflammation & Allergy Drug Discovery publishes full-length/mini reviews, research articles, letters, case reports, perspectives, systematic reviews and thematic issues in the field of inflammation and allergy research, including new strategies in diagnosis, treatment and prevention of allergic and inflammatory diseases. The journal covers all pharmacological aspects of inflammation and allergy, including mediators of inflammation and allergy, as well as cellular processes and molecular mechanisms involved in the production of inflammatory and hypersensitivity reactions. The journal encourages submission of articles on anti-inflammatory and anti-allergy therapies, acute and chronic inflammation, allergic and immunologic diseases, chronic obstructive pulmonary disease (COPD) allied inflammation, irritant induced asthma, respiratory aids, clinical immunology, primary immune deficiencies, allergic rhinitis, drug allergies, atopic dermatitis, allergy associated skin test and their interpretation, occupational and environmental allergy, allergen immunotherapy, herbal or traditional medicines for the treatment of allergy and inflammation. Articles on important and recent patents in the field is also included in the journal. The journal is essential reading for all researchers involved in inflammation and allergy drug design and discovery.